Table 4.

Cost and effectiveness in subgroup with baseline HbA1c >7%

Arm	Mean total cost (€) (95% CI)	Mean QALYs (95% CI)	Cost-effectiveness
CBI	3516.44 (3207.58 to 3825.31)	1.62 (1.59 to 1.67)	Dominated
UC	3492.08 (3092.06 to 3892.1)	1.70 (1.66 to 1.73)	Dominated
PFI	3310.96 (2981.6 to 3640.32)	1.71 (1.68 to 1.75)	Dominated
PTI	3117.46 (2763.4 to 3471.53)	1.72 (1.69 to 1.75)	Dominant

CBI, combined intervention for patients and professionals; CI, Confidence interval; HbA1c, glycated haemoglobin; PFI, intervention only for healthcare professionals in primary care; PTI, intervention only for patients and family members; QALY, quality-adjusted life-years; UC, usual care (control group).